Pay in 4 interest-free payments of $6.04 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
May improve insulin sensitivity: Some studies show GIP agonism modulates lipid metabolism and energy homeostasis 1,3
Transforming growth factor B1 and additional renoprotective effect of combination ACE inhibitor and angiotensin II receptor blocker in hypertensive subjects with minor renal abnormalities: A 24-week randomized controlled trial
While current studies demonstrate promising results, understanding the long-term effects of GLP-1 receptor agonists will be crucial for establishing their role in chronic obesity management
Patients with diabetes are considered for cardiovascular disease secondary prevention because their risk level is similar to that reported in patients without diabetes who have already suffered a myocardial infarction
Key Takeaways Retatrutide is a triple-receptor agonist targeting GLP-1, GIP, and glucagon simultaneously
There is no quality assurance framework governing these products, and consumers have no means of verifying their contents
